Excision repair cross-complementing 1(ERCC1) expression in gallbladder cancer is a prognostic factor?

被引：0
|
作者：
Roa, I. [1 ]
De Aretxabala, X. [2 ]
Lantadilla, S. [1 ]
机构：
[1] Univ Desarrollo, Clin Alemana, Fac Med, Dept Pathol, Santiago, Chile
[2] Clin Alemana, Dept Surg, Santiago, Chile
来源：
HISTOPATHOLOGY | 2008年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
364
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [21] miR-138-5p modulates the expression of excision repair cross-complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin
    Ning, Jie
    Jiao, Yang
    Xie, Xiaoque
    Deng, Xuefei
    Zhang, Yiyin
    Yang, Yuexin
    Zhao, Chenchen
    Wang, Hua
    Gu, Kangsheng
    ONCOLOGY REPORTS, 2019, 41 (02) : 1131 - 1139
  • [22] Immunohistochemical staining of the Excision Repair Cross-Complementing 1 (ERCC1) protein as predictor for benefit of adjuvant chemotherapy (CT) in the International Lung Cancer Trial (IALT).
    Soria, J.
    Haddad, V.
    Olaussen, K. A.
    Fouret, P.
    Dunant, A.
    Filipits, M.
    Popper, H. H.
    Andre, F.
    Le Chevalier, T.
    Brambilla, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 366S - 366S
  • [23] Excision repair cross-complementing group 1 (ERCC1) gene polymorphism is associated with local toxicity and tumor regression in rectal cancer patients treated with chemoradiation
    Gusella, M.
    Capirci, C.
    Crepaldi, G.
    Marinelli, R.
    Bolzonella, C.
    Ferrazzi, E.
    ANNALS OF ONCOLOGY, 2006, 17 : 105 - 105
  • [24] RETRACTED: Chemoresistance in gastric cancer is attributed to the overexpression of excision repair cross-complementing 1 (ERCC1) caused by microRNA-122 dysregulation (Retracted Article)
    Song, Ai-Ling
    Zhao, Lei
    Wang, Yan-Wei
    He, Dong-Qiang
    Li, Yu-Min
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (12) : 22485 - 22492
  • [25] The role of thymidylate synthase (TS) and excision repair cross-complementing group 1 (ERCC1) immunohistochemical expression in malignant pleural mesothelioma patients treated with pemetrexed and carboplatin
    Zucali, P.
    Destro, A.
    Ceresoli, G. L.
    Gianoncelli, L.
    Lorenzi, E.
    De Vincenzo, F.
    Simonelli, M.
    Giordano, L.
    Roncalli, M.
    Santoro, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 543 - 543
  • [26] Prognostic values of excision repair cross-complementing genes mRNA expression in ovarian cancer patients
    Zhao, Menghuang
    Li, Saisai
    Zhou, Lulu
    Shen, Qi
    Zhu, Haiyan
    Zhu, Xueqiong
    LIFE SCIENCES, 2018, 194 : 34 - 39
  • [27] Predictive and prognostic value of excision repair cross-complementing group 1 in patients with advanced gastric cancer
    Yasuhide Yamada
    Kengo Nagashima
    Mizutomo Azuma
    Mitsuko Masutani
    Hitoshi Ichikawa
    Satoru Iwasa
    Naoki Takahashi
    Hidekazu Hirano
    Keisuke Kanato
    Nozomu Machida
    Takahiro Kinoshita
    Hiroaki Hata
    Hisato Kawakami
    Daisuke Takahari
    Narikazu Boku
    Yukinori Kurokawa
    Masanori Terashima
    Takaki Yoshikawa
    Shigeki Sekine
    Nobuyoshi Hiraoka
    BJC Reports, 2 (1):
  • [28] Analysis of excision repair cross complementing group 1 (ERCC1) expression in squamous cell carcinoma of the head and neck (SCCHN)
    Mehra, Ranee
    Cai, Qi K.
    Zhu, Fang
    Godwin, Andrew
    Burtness, Barbara
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [29] Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma
    Peng, Haiying
    Yao, Shaobo
    Dong, Qingyu
    Zhang, Yanxia
    Gong, Weihong
    Jia, Zhongyao
    Yan, Li
    MEDICINE, 2018, 97 (31)
  • [30] Clinical significance of dihydropyrimidine dehydrogenase (DPD), epidermal growth factor receptor (EGFR), and excision repair cross-complementing gene 1 (ERCC1) gene expression of tumor tissue in patients with advanced gastric cancer
    Nishina, T.
    Matsubara, J.
    Toshikazu, M.
    Yamada, Y.
    Kajiwara, T.
    Shimoda, T.
    Okayama, Y.
    Sugimoto, Y.
    Oka, T.
    Shirao, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345